Company intelligence / Profile preview

D2EMOTION

Cheongju, Chungcheongbuk-do, South Koread2emotion.com ↗

Ownership: Private
Development stage: Commercial

Overview

D2EMOTION develops and provides clinically validated digital therapeutics using artificial intelligence and software technologies to treat, manage, and prevent a wide range of diseases and disorders. Their products are designed to deliver evidence-based interventions via software platforms.

Therapeutic areas: OtherPsychiatryInfectious Diseases
Modalities: Non-pharmacological therapyDigital therapeutics (DTx)Software-based intervention
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on D2EMOTION.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D2EMOTION.

Explore the full profile